Parthenon Capital, a private equity firm, completed the investment in RxSense, a pharmacy software company. Financial terms were not disclosed. “We’re thrilled to partner with the Parthenon Capital team, which brings tremendous experience and strategic value to RxSense. Parthenon’s experience building and supporting franchise companies in healthcare technology as well as the addition of our new board members will create a significant advantage for us as we continue to grow our business and develop solutions that meaningfully improve healthcare transparency and the affordability of prescriptions," Rick Bates, RxSense Chairman and CEO.